Ccm Investment Advisers LLC Gilead Sciences, Inc. Transaction History

Ccm Investment Advisers LLC

  • $848 Million
  • Q2 2024

A detailed history of Ccm Investment Advisers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ccm Investment Advisers LLC holds 10,925 shares of GILD stock, worth $913,439. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,925
Previous 12,130 9.93%
Holding current value
$913,439
Previous $888,000 15.65%
% of portfolio
0.09%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024
SELL
$63.15 - $72.88 $76,095 - $87,820
-1,205 Reduced 9.93%
10,925 $749,000
Q1 2024

May 17, 2024
SELL
$71.58 - $87.29 $9.33 Million - $11.4 Million
-130,405 Reduced 91.49%
12,130 $888,000
Q4 2023

Mar 05, 2024
SELL
$73.27 - $83.09 $902,466 - $1.02 Million
-12,317 Reduced 7.95%
142,535 $11.5 Million
Q3 2023

Dec 08, 2023
BUY
$73.94 - $80.67 $462,716 - $504,832
6,258 Added 4.21%
154,852 $11.6 Million
Q2 2023

Aug 21, 2023
BUY
$76.01 - $86.7 $428,164 - $488,381
5,633 Added 3.94%
148,594 $11.5 Million
Q1 2023

May 17, 2023
BUY
$77.31 - $88.08 $2.81 Million - $3.2 Million
36,326 Added 34.07%
142,961 $11.9 Million
Q4 2022

Feb 15, 2023
SELL
$62.32 - $89.47 $704,465 - $1.01 Million
-11,304 Reduced 9.58%
106,635 $9.15 Million
Q3 2022

Nov 09, 2022
BUY
$59.54 - $68.01 $810,339 - $925,616
13,610 Added 13.05%
117,939 $7.28 Million
Q2 2022

Jul 27, 2022
SELL
$57.72 - $65.01 $303,030 - $341,302
-5,250 Reduced 4.79%
104,329 $6.45 Million
Q1 2022

May 03, 2022
SELL
$57.92 - $72.58 $2.67 Million - $3.35 Million
-46,149 Reduced 29.63%
109,579 $6.51 Million
Q4 2021

Feb 01, 2022
BUY
$64.88 - $73.64 $93,037 - $105,599
1,434 Added 0.93%
155,728 $11.3 Million
Q3 2021

Oct 26, 2021
BUY
$67.69 - $73.03 $363,630 - $392,317
5,372 Added 3.61%
154,294 $10.8 Million
Q2 2021

Jul 30, 2021
BUY
$63.47 - $69.35 $417,315 - $455,976
6,575 Added 4.62%
148,922 $10.3 Million
Q1 2021

May 07, 2021
BUY
$60.0 - $68.46 $564,000 - $643,523
9,400 Added 7.07%
142,347 $9.2 Million
Q4 2020

Feb 25, 2021
SELL
$56.65 - $64.55 $156,807 - $178,674
-2,768 Reduced 2.04%
132,947 $7.75 Million
Q3 2020

Nov 10, 2020
SELL
$62.1 - $78.08 $168,353 - $211,674
-2,711 Reduced 1.96%
135,715 $8.58 Million
Q2 2020

Aug 10, 2020
BUY
$72.34 - $84.0 $260,713 - $302,736
3,604 Added 2.67%
138,426 $10.7 Million
Q1 2020

May 22, 2020
SELL
$62.63 - $80.22 $104,967 - $134,448
-1,676 Reduced 1.23%
134,822 $10.1 Million
Q4 2019

Feb 20, 2020
BUY
$61.62 - $67.78 $194,472 - $213,913
3,156 Added 2.37%
136,498 $8.87 Million
Q3 2019

Nov 19, 2019
BUY
$62.51 - $69.0 $8.34 Million - $9.2 Million
133,342 New
133,342 $8.45 Million

Others Institutions Holding GILD

# of Institutions
1,879
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ccm Investment Advisers LLC Portfolio

Follow Ccm Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email